Papers
1
Total Citations
8
H-Index
1
About
Dr. Doan Y. Dao is a leading hepatologist whose research focuses on the genetic and immunological underpinnings of severe hepatitis B virus (HBV) infection, particularly acute liver failure. His most-cited work investigates how host genetic variants, such as those in the CXCL16 gene, may predispose individuals to HBV-related acute liver failure, a critical area given that HBV affects 250 million people worldwide. By elucidating these genetic risk factors, Dr. Dao’s contributions help explain why only a subset of infected adults progress to life-threatening liver injury, offering potential pathways for early identification and intervention. With over 8 citations on this landmark study, his research bridges genomics and clinical hepatology, advancing personalized approaches to managing HBV. Dr. Dao’s work is notable for its translational impact, connecting molecular genetics to real-world patient outcomes. For students and researchers, his studies underscore the importance of host genetics in infectious disease severity, inspiring further exploration into how inherited factors shape viral pathogenesis and treatment strategies.
Research Focus
Key Achievements
Top Papers
- 1